This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Peter Le Souëf / Rose Maciewicz

Professor Peter Le Souëf
Professor Peter Le Souëf is a recognised international leader in paediatric respiratory research. He trained at 3 centres of excellence: University College Hospital, London; Hospital for Sick Children, Toronto; Royal Children’s Hospital, Melbourne. He has published 243 papers in peer-reviewed journals with an H-index of 53 and over 9,000 citations. His research achievements have been recognised internationally particularly for his innovative research ideas and for developing new fields of research, many of which are translational, including: new techniques for assessing respiratory physiology in infants (including the most accurate assessment of infants’ respiratory function in current use); aerosol drug delivery in children (his work largely defined current understanding in this field); immunogenetics in childhood asthma; evolution of the human immune system (relationship between climate and immune system responses); and immunological regulation in acute severe respiratory virus infection in children.

Rose Maciewicz
My role is to establish and lead external collaborative programmes such as the precompetitive collaboration between GSK and University of Manchester (the Manchester Collaborative Centre for Inflammation research), the GLAZgo Discovery Centre at the Institute of Infection, Immunity and Inflammation at the University of Glasgow and more focused collaboration like this with Professor Peter Le Souëf and his team. The objective of these high quality scientific interactions is to identify new ways to reveal the cellular / molecular nature that underpins the pathology in our disease areas of interest to develop new ways to ultimately provide enhanced patient benefit. I also provide scientific support and challenge to the clinical and preclinical projects within the iMed. I have established and lead a highly-regarded postdoctoral programme in AstraZeneca that currently supports over 100 internal post-docs to support innovative science and also train the next generation of pharmaceutical scientific leaders.

You are viewing: All posts Reset filters

Our Other Authors